lilly cease and desist tirzepatide Letters to Compounders : r/tirzepatidecompound It Begins: Eli Lilly Fires

Cessation of GLP-1 has been found to result in weight gain

6.7% of patients taking GLP-1 developed NAION compared to 0.8% of patients taking other medications

Since muscle breakdown can increase your risk of falls, illness, and other health problems, monitoring your strength and physical function is just as important as tracking your weight

The decision depends on your individual health situation, weight loss goals, and how well you've incorporated sustainable habits

FDA Approval and Intended Use Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are specifically FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition